首页> 外文OA文献 >Gene expression in ovarian carcinoma and correlation with prognostic factors and survival - A study of mRNA and miRNA profiling and differentiality
【2h】

Gene expression in ovarian carcinoma and correlation with prognostic factors and survival - A study of mRNA and miRNA profiling and differentiality

机译:卵巢癌中的基因表达与预后因素和生存期的相关性 - mRNa和miRNa分析及鉴别的研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

List of papers.Paper I Elgaaen BV, Haug KBF, Wang J, Olstad OK, Fortunati D, Onsrud M, Staff AC, Sauer T, Gautvik KM. POLD2 and KSP37 (FGFBP2) correlate strongly with histology, stage and outcome in ovarian carcinomas. PLoS One. 2010;5(11):e13837. © 2010 Elgaaen et al. This is an open-access article distributed under the terms of the Creative Commons Attribution LicensePaper II Elgaaen BV, Olstad OK, Sandvik L, Ødegaard E, Sauer T, Staff AC, Gautvik KM. ZNF385B and VEGFA are strongly differentially expressed in serous ovarian carcinomas and correlate with survival. PLoS One. 2012;7(9):e46317. © Elgaaen et al. This is an open-access article distributed under the terms of the Creative Commons Attribution LicensePaper III Elgaaen BV, Olstad OK, Haug KBF, Brusletto B, Sandvik L, Staff AC, Gautvik KM, Davidson B. Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic marker. Author version, published in: BMC Cancer 2014, 14:80 © 2014 Vilming Elgaaen et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License
机译:论文清单纸I Elgaaen BV,Haug KBF,Wang J,Olstad OK,Fortunati D,Onsrud M,Staff AC,Sauer T,Gautvik KM。 POLD2和KSP37(FGFBP2)与卵巢癌的组织学,分期和预后密切相关。 PLoS一。 2010; 5(11):e13837。 ©2010 Elgaaen等人。本文是根据知识共享署名许可协议纸II Elgaaen BV,Olstad OK,Sandvik L,ØdegaardE,Sauer T,Staff AC,Gautvik KM的条款发行的开放获取文章。 ZNF385B和VEGFA在浆液性卵巢癌中强烈差异表达,并与存活率相关。 PLoS一。 2012; 7(9):e46317。 ©Elgaaen等。这是一个开放获取的文章,已根据知识共享署名许可协议的条款分发。纸III Elgaaen BV,Olstad OK,Haug KBF,Brusletto B,Sandvik L,Staff AC,Gautvik KM,DavidsonB。细胞卵巢癌将包括miR-200c-3p在内的差异表达的miRNA鉴定为预后标记。作者版本,发表于:BMC Cancer 2014,14:80©2014 Vilming Elgaaen等;被许可人BioMed Central Ltd.。这是根据知识共享署名许可协议条款发布的开放访问文章

著录项

  • 作者

    Elgaaen, Bente Vilming;

  • 作者单位
  • 年度 2014
  • 总页数
  • 原文格式 PDF
  • 正文语种 en
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号